Introduction
Imidazo [1,5-a] [1, 4] benzodiazepines are well documented to exhibit potent activity at GABA A /Bz receptors. This series belongs to one of the very few chemical families, which have been extensively investigated for GABA A /Bz receptor mediated activity. 1, 2 Flumazenil (Ro 15-1788), an imidazo [1,5-a] [1, 4] benzodiazepine, was earlier shown to bind to central GABA A receptors with little or no intrinsic agonist activity, but with the ability to block the activity of an agonist or inverse agonist at GABA A /Bz receptors. 2 It is employed principally as an antidote to reverse the effect of exogenous benzodiazepines. 3 More recently ligands such as flumazenil have been shown to behave as weak inverse agonists or weak agonists depending on the biological paradigm employed. Many procedures have been reported to date to synthesize this imidazo-type of structure. 4, 5 Most of them have been achieved in low yield through an iminophosphate/ chloride intermediate.
As part of a program directed toward the development of clinically relevant imidazo [1,5-a] [1, 4] benzodiazepines, 1, 6 the construction of the imidazo ring was considered a crucial step for the synthesis of gram quantities of imidazobenzodiazepine analogues. The previous process of using ethyl isocyanoacetate and iminophosphates/ chlorides 7,8 was employed coupled with different solvents and bases, but the yields of these reactions were very low (15-30%). Since this step was highly convergent and at the very end of the synthetic route, it affected the overall economy of the route in a deleterious manner. It was, therefore, of interest to improve the annulation sequence for this series of CNS-active ligands.
Certainly a one-pot annulation process for the construction of imidazobenzodiazepines had been developed. 7, 8 This procedure permitted the condensation of the less stable iminophosphates with ethyl isocyanoacetate under basic conditions without isolation of the less stable iminophosphates and the preformation of the carbanion of ethyl isocyanoacetate. For instance, Watjen et al. 7a had reported the formation of iminophosphates by using NaH or LDA in DMF, and then directly reacting this mixture with ethyl isocyanoacetate and potassium tert-butoxide to offer the imidazo molecules in 47% yield. Fryer and co-workers
had reported the use of potassium tert-butoxide as the base in both steps, and DMF as well as THF were chosen as solvents in these cases; however, this process gave the ligands in only 44% yield. The latest report from Fryer's procedure gave the target imidazo framework in 30% yield.
8
Scope and Limitations
To improve the one-pot annulation reaction, the procedure was modified and after many attempts it was found that the ratio of the reagent combination and reaction temperature were critical for good yields on a consistent basis. As shown in Scheme 1, the initial amount of potassium tert-butoxide used to form the iminophosphates should be kept at 1.1 equivalents as compared to the amides 1a-k. The yield of the reaction was much lower if more potassium tert-butoxide (>1.1 equiv) was employed. The amount of diethyl chlorophosphate (used as received) employed was only slightly higher (1.3 equiv) than the potassium tert-butoxide to convert all the starting amide into the desired iminophosphates 2a-k. Importantly, the addition of ethyl isocyanoacetate, followed by the second addition of potassium tert-butoxide should be carried out at low temperature (-35°C is recommended). However, a temperature lower than -35°C (such as -78°C) was also acceptable in this procedure and the second addition of potassium tert-butoxide was kept at 1.1 equivalents. This procedure made the separation of the product much easier, which was critical for gram scale reactions. Most of the desired imidazobenzodiazepines were precipitated from diethyl ether after workup for no chromatography was needed.
A variety of different amidobenzodiazepines 1a-h were chosen as substrates for this study (Table 1) . Both the 5-phenylbenzodiazepines 1a-f and N-methyl-6-oxobenzodiazepines 1g,h readily condensed with ethyl isocyanoacetate to give the desired imidazobenzodiazepines 3a-k in 70-89% yields in this improved process. The substituents in ring A such as F, Cl, Br of 1a-h did not affect the yield of the process. The a-substituted amidobenzodiazepines 1c-e, and 1i, which are more hindered than their unsubstituted parents 1a,b and 1f-j, also gave the imidazo analogues in 70-81% yields. In the case of optically active substrates 1c-e, and 1i, this procedure provided the desired imidazo products without loss in optical activity.
The R-and S-isomers produced have much different BzR/ GABAergic receptor binding profiles. All of these reactions can be scaled up with no difficulty. The lesser amounts of 3d-g simply reflect the lesser need for this material. When this process was employed for reactions of tert-butyl isocyanoacetate, the corresponding imidazobenzodiazepine 3k was obtained in 70% yield. In summary, an efficient, practical, improved, and one-pot annulation reaction for the construction of potent BzR active imidazobenzodiazepines is described. A variety of substrates were successfully employed in this procedure. This one-pot process required neither the isolation of the unstable intermediates nor does it require the preformation of the carbanion of the isocyanocetate. Moreover, potassium tert-butoxide is a safer and easier-to-handle base for scale-up, as compared to other bases such as NaH, LHMDS, and LDA. In addition, no chromatography was required for this process. After stirring the mixture at 0°C for 20 min, the reaction mixture was cooled to -35°C and diethyl chlorophosphate (1.3 mmol) was added slowly. After stirring this mixture at 0°C for 30 min, the reaction flask was cooled to -35°C and ethyl isocyanoacetate (1.1 mmol) was added, followed by the addition of t-BuOK (1.1 mmol).
After stirring this mixture at r.t. for 4 h, the reaction solution was quenched with sat. aq NaHCO 3 (30 mL) and extracted with EtOAc (3 × 50 mL ). The combined organic layers were dried (Na 2 SO 4 ), concentrated, and the product was precipitated from Et 2 O to give most of the imidazobenzodiazepine. The mother liquor was purified by flash chromatography on silica gel (40-60% EtOAc in hexanes) to afford additional imidazobenzodiazepine (yields 70-89%) ( Table 1) . 76 mmol) in anhyd THF (1500 mL) at 0°C and stirred for 20 min. The reaction mixture was cooled to -35°C and diethyl chlorophosphate (10.42 mL, 72.49 mmol) was added slowly. After stirring at 0°C for 30 min, the mixture was cooled to -78°C and ethyl isocyanoacetate (6.70 mL, 61.33 mmol) was added followed by the addition of t-BuOK (6.88g, 61.33 mmol). After stirring at r.t. for 4 h, the reaction was quenched with sat. aq NaHCO 3 (500 mL) and extracted with EtOAc (3 × 1000 mL). The combined organic layers were dried (Na 2 SO 4 ) and concentrated to give a solid residue. This solid residue was treated with Et 2 O (250 mL) and the product 3j was precipitated as an off-white solid. The mother liquor was further purified by flash chromatography on silica gel (gradient elution 40-60% EtOAc in hexane) to afford additional product 3j with an overall yield of 72% (14.61 g). 4 .46 (q, J = 7. 
